Literature DB >> 22206251

CD93: recent advances and implications in disease.

Mallary C Greenlee-Wacker1, Manuel D Galvan, Suzanne S Bohlson.   

Abstract

While it has been known for some time that CD93 regulates several processes involved in innate immunity and inflammation including phagocytosis and adhesion, the function of CD93 in disease progression is only now being elucidated. Recent in vivo studies in mice, and genome wide studies in mice and humans, have provided clues about its molecular function. Following a comprehensive review of CD93 expression patterns, this review will focus on recent findings over the last three years that address the putative function of CD93 in inflammation and innate immunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22206251     DOI: 10.2174/138945012799424651

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  14 in total

1.  CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.

Authors:  Mark R Griffiths; Marina Botto; Bryan Paul Morgan; James W Neal; Philippe Gasque
Journal:  Immunology       Date:  2018-07-11       Impact factor: 7.397

2.  Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways.

Authors:  Pamela E Blackshear; Arun R Pandiri; Thai-Vu T Ton; Natasha P Clayton; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2013-08-26       Impact factor: 1.902

3.  High-resolution transcriptome of human macrophages.

Authors:  Marc Beyer; Michael R Mallmann; Jia Xue; Andrea Staratschek-Jox; Daniela Vorholt; Wolfgang Krebs; Daniel Sommer; Jil Sander; Christina Mertens; Andrea Nino-Castro; Susanne V Schmidt; Joachim L Schultze
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

4.  CD93 gene polymorphism is associated with disseminated colorectal cancer.

Authors:  Renate S Olsen; Mikael Lindh; Emina Vorkapic; Roland E Andersson; Niklas Zar; Sture Löfgren; Jan Dimberg; Andreas Matussek; Dick Wågsäter
Journal:  Int J Colorectal Dis       Date:  2015-05-26       Impact factor: 2.571

5.  Bortezomib resistance can be reversed by induced expression of plasma cell maturation markers in a mouse in vitro model of multiple myeloma.

Authors:  Holly A F Stessman; Aatif Mansoor; Fenghuang Zhan; Michael A Linden; Brian Van Ness; Linda B Baughn
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

6.  Platelets direct monocyte differentiation into epithelioid-like multinucleated giant foam cells with suppressive capacity upon mycobacterial stimulation.

Authors:  Yonghong Feng; Anca Dorhoi; Hans-Joachim Mollenkopf; Hongyun Yin; Zhengwei Dong; Ling Mao; Jun Zhou; Aixiao Bi; Stephan Weber; Jeroen Maertzdorf; Gang Chen; Yang Chen; Stefan H E Kaufmann
Journal:  J Infect Dis       Date:  2014-07-01       Impact factor: 5.226

7.  Soluble CD93 in Serum as a Marker of Allergic Inflammation.

Authors:  Hye Jung Park; Heejae Han; Sang Chul Lee; Young Woong Son; Da Woon Sim; Kyung Hee Park; Yoon Hee Park; Kyoung Yong Jeong; Jung Won Park; Jae Hyun Lee
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

8.  Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.

Authors:  Yi Sun; Wei Chen; Robert J Torphy; Sheng Yao; Gefeng Zhu; Ronggui Lin; Roberta Lugano; Emily N Miller; Yuki Fujiwara; Li Bian; Linghua Zheng; Sudarshan Anand; Fan Gao; Weizhou Zhang; Sarah E Ferrara; Andrew E Goodspeed; Anna Dimberg; Xiao-Jing Wang; Barish H Edil; Carlton C Barnett; Richard D Schulick; Lieping Chen; Yuwen Zhu
Journal:  Sci Transl Med       Date:  2021-07-28       Impact factor: 17.956

9.  TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells.

Authors:  Sahana Suresh Babu; Yanet Valdez; Andrea Xu; Alice M O'Byrne; Fernando Calvo; Victor Lei; Edward M Conway
Journal:  BMC Cancer       Date:  2014-02-20       Impact factor: 4.430

10.  Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Jun Ishizaki; Ayako Takemori; Koichiro Suemori; Takuya Matsumoto; Yoko Akita; Ken-Ei Sada; Yukio Yuzawa; Koichi Amano; Yoshinari Takasaki; Masayoshi Harigai; Yoshihiro Arimura; Hirofumi Makino; Masaki Yasukawa; Nobuaki Takemori; Hitoshi Hasegawa
Journal:  Arthritis Res Ther       Date:  2017-09-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.